Stefan Neubauer

Microvisk Ltd. engages in the manufacture and development of micro-viscometer based on micro electro mechanical sensors technology for medical field. The firm's products include CoagMax, CoagLite, CoagManager and SmartStrip. It develops technology for the detection and analysis of a fluid's properties using a cantilever-based micro-viscometer. The company was founded by Vladislav Djakov, Paul Morgan Vernon and Jeremy Burford Peckham in 2004 and is headquartered in Oxford, the United Kingdom.

Oxford University Innovation Ltd (Oxford University Innovation) is a venture capital subsidiary of University of Oxford founded in 1987 and spun out in 2010. The firm is headquartered in London, United Kingdom.

Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.

OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom.

Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom.

OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom.

ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom.

Commerce Decisions Ltd. develops enterprise software. It offers software and services to support the procurement and post contract review processes for both buyers and suppliers. The company was founded by Steven Dey and John Thompson and is headquartered in Oxfordshire, the United Kingdom.

Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom.

Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom.

Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK.